Testing the hypothesis that a deficiency in VMAT2 contributes to the development of Parkinson’s disease, a genetic mouse model investigated the consequence of systemic VMAT2 deficiency and revealed the replication of motor and nonmotor Parkinson’s symptoms as well as age-dependent dopaminergic neurodegeneration19,20. The gene discussed is SLC18A2; the disease is Parkinsonism.